Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome
NCT01144741 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2
Last updated 2022-06-21
Summary
Freeman-Sheldon syndrome (FSS) is a rare muscle disorder present before birth, involving primarily problems of the face and skull and the hands and feet.
This is a study of problems, experiences, helpful treatments, and quality of life focusing on patients with FSS but including patients with Sheldon-Hall syndrome (SHS), distal arthrogryposis type 1 (DA1), and distal arthrogryposis type 3 (DA3), also called Gorden syndrome. These and related disorders are very challenging to treat, partly because the big differences in individual patients and lack of information on previous clinical experience with treatment options. It is hoped the study will identify areas for further research in physiology and therapy.
This study will cover all types of treatment \[medical (non-surgical), including psychiatric, and surgical treatments\], even unconventional. It also includes questions about effects on the patient's thoughts, feelings, quality of life, and relationship with siblings, family, and parents' and if any intervention was required or advised. This study will also look for similarities and differences in patients who meet the head and face part of the diagnostic criteria but do not meet all other parts and patients who met the full diagnostic criteria. There will be questions about problems or experiences to investigate if both groups of patients may have the same syndrome. Treatment success depends on getting a correct diagnosis.
Conditions
- Freeman-Sheldon Syndrome
- Arthrogryposis Distal Type 2A
- Whistling Face Syndrome
- Craniocarpotarsal Dysplasia
- Craniocarpotarsal Dystrophy
- Freeman-Sheldon Syndrome Variant
- Sheldon-Hall Syndrome
- Arthrogryposis Distal Type 2B
- Gordon Syndrome
- Arthrogryposis Distal Type 3
- Arthrogryposis Distal Type 1
- Arthrogryposis, Distal, Type 1A
- Arthrogryposis Distal Type 1B
- Arthrogryposis, Distal
- Craniofacial Abnormalities
- Arthrogryposis
Interventions
- OTHER
-
PTSD Checklist-Civilian (PCL-C)
Completed by patients before the interview; it is a 17-item survey listing of symptoms of posttraumatic stress disorder.
- OTHER
-
Modified Flanagan Quality of Life Scale
Completed by patients before the interview; it is a 16-item survey designed for use in persons with chronic illness.
- OTHER
-
Center for Epidemiologic Studies Depression Scale (CES-D)
Completed by patients before the interview; it is a 20-item survey that asks about depressive feelings and behaviours in the past week.
- OTHER
-
Functional Enquiry (or Review of Systems) Form
Completed during the interview; it is a checklist of medical problems.
- OTHER
-
Study of Therapeutic Outcomes and Practices in Freeman-Sheldon Syndrome (STOP-FSS) Questionnaire
The STOP Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.
- OTHER
-
FSRG Semi-Structured Quality of Life Interview (FSRG SSQLI)
Completed after data analysis from the existing surveys, it will be a specific quality of life interview, taking into consideration individual's total health outcome.
- OTHER
-
Medical Records Review
Review of medical records will be used, along with STOP-FSS Survey to assess patient histories and outcomes.
Sponsors & Collaborators
-
Freeman-Sheldon Research Group, Inc.
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2022-06-14
- Completion
- 2022-06-14
Countries
- United States
Study Locations
More Related Trials
-
Decisional Capacity and Informed Consent in Fragile X Syndrome
NCT02465931 ·Status: COMPLETED ·Phase: NA
-
An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression
NCT06079567 ·Status: RECRUITING ·Phase: NA
-
Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)
NCT02095015 ·Status: TERMINATED
-
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
NCT04635891 ·Status: RECRUITING
-
Natural History Study of Children With Metachromatic Leukodystrophy
NCT01963650 ·Status: TERMINATED
-
Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia
NCT06560346 ·Status: WITHDRAWN
-
Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism
NCT05047354 ·Status: RECRUITING
-
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
NCT01675674 ·Status: TERMINATED
-
Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)
NCT01822184 ·Status: COMPLETED
-
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
NCT02435030 ·Status: COMPLETED
-
Study of Acamprosate in Fragile x Syndrome
NCT01911455 ·Status: COMPLETED ·Phase: PHASE1
-
Neurophysiological and Acute Pharmacological Studies in FXS Patients
NCT02998151 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome
NCT01325220 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
NCT05418049 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)
NCT05109793 ·Status: COMPLETED
-
Measurement of Frataxin mRNA in Biofluids
NCT06496451 ·Status: COMPLETED
-
Rasch-analysis of Clinical Severity in FSHD
NCT02766985 ·Status: COMPLETED
-
A Gene Therapy Study in Patients With Gaucher Disease Type 1
NCT05324943 ·Status: COMPLETED ·Phase: PHASE1
-
Studies in Patients With Tuberous Sclerosis Complex
NCT03276195 ·Status: COMPLETED
-
EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes
NCT01711606 ·Status: TERMINATED
-
Ganaxolone Treatment in Children With Fragile X Syndrome
NCT01725152 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History Studies of Mucopolysaccharidosis III
NCT02037880 ·Status: COMPLETED
-
Mucopolysaccharidosis Type II Observational
NCT04591834 ·Status: WITHDRAWN
-
Natural History of Rett Syndrome & Related Disorders
NCT02738281 ·Status: COMPLETED
-
Mucopolysaccharidosis Type II Natural History
NCT03529786 ·Status: COMPLETED